HYDROCORTISONE BUTYRATE

Post-LOE

hydrocortisone butyrate

Precision BioSciences

ANDATOPICALLOTION

Approved

Aug 2018

Lifecycle

Post-LOE

Competitive Pressure

30/100

Data completeness

3/8 — Basic

HYDROCORTISONE BUTYRATE (hydrocortisone butyrate) by Precision BioSciences is 12. Approved for atopic dermatitis. First approved in 2018.

Drug data last refreshed 18h ago

Mechanism of Action

12.1 Mechanism of Action Topical corticosteroids share anti-inflammatory, antipruritic, and vasoconstrictive properties. The mechanism of the anti-inflammatory activity of the topical corticosteroids is unclear. However, corticosteroids are thought to act by the induction of phospholipase A 2…

Indications (1)

atopic dermatitis

Worked on HYDROCORTISONE BUTYRATE at Precision BioSciences? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.